Delivery Order SPE2DB22D3102-SPE2DB25FL2YE
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Adenosine 12 mg/4 mL syringes with a ceiling value of $1,027.81. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing under a delivery order arrangement, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $3,091.99 to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL syringes on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a $3,957.51 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Adenosine 6 mg/2 mL syringes. This firm fixed price contract, with an ultimate completion date of September 17, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,993.45 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Adenosine 12 mg/4 ml syringes. The contract, which is not set-aside and competitively awarded, represents a firm fixed price delivery order with an ultimate completion date of August 26, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Adenosine Injection with a ceiling value of $4,667.56. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, and represents a small-value pharmaceutical transaction typical of the agency's medical procurement operations. The order will be fulfilled from AmerisourceBergen's Corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,136.88 delivery order to AmerisourceBergen Drug Corp for the supply of Adenosine 12 mg/4 mL vials on July 18, 2025, with completion targeted for July 21, 2025. The award utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Adenosine 12 mg/4 mL vials with a ceiling value of $1,084.19. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and no set-aside designation was used in the award. The work will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adenosine 12mg/4ml (10 units) on August 21, 2025. This firm fixed price delivery order, valued at $2,154.70, represents a competitively awarded, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,580,139 adenosine 12 mg/4 ml syringes. The contract has a completion date of February 8, 2024 and a potential value of $2,309.08. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,292.82 to AmerisourceBergen Drug Corp for the supply of Adenosine 12mg/4mL in a quantity of 10 units. This firm fixed-price, competitively awarded delivery order was issued on December 21, 2024, with an ultimate completion date of the same day. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its Corporate...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2YEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Adenosine 12 mg/4 ml syringes with a ceiling value of $2,264.34. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains a significant portfolio of delivery orders across multiple therapeutic domains in support of Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/10/25 |